Chronic Heart Failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with CHF such as dilated cardiomyopathy and ischemic 2) Patients who agree the informed consent 3) Patients who can move to Waon equipment by their selves or by wheel-chair from their room
Exclusion criteria
Exclusion criteria: 1) 1) Untreated HF patients 2) Severe aortic stenosis which pressure gradient is 50 mmHg or more. 3) Hypertrophic obstructive cardiomyopathy with severe LV and out-flow obstruction (the pressure gradient is 50 mmHg or more). 4) Patients with active infection or fever with 37 cent-degrees or more. 5) Patients who had myocardial infarction or stroke within 6 months. 6) Cancer, or less than 5 years from healing cancer. 7) Patients treated with hemodialysis 8) Patients whose body weight is 135 kg or more. 9) Patients who are judged as inappropriate subjects by physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of plasma BNP levels 2 weeks after the start of study. | — |
Secondary
| Measure | Time frame |
|---|---|
| NYHA functional class, 6 min walk distance, cardiothoracic ratio of chest Xp, ejection fraction of echocardiogram, heart rate, arrhythmia, bundle branch block, incidence of adverse event | — |
Countries
Japan
Contacts
Kagoshima University Cardiovascular Medicine and Hypertension